1. Home
  2. EPR vs BLCO Comparison

EPR vs BLCO Comparison

Compare EPR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPR
  • BLCO
  • Stock Information
  • Founded
  • EPR 1997
  • BLCO 1853
  • Country
  • EPR United States
  • BLCO Canada
  • Employees
  • EPR N/A
  • BLCO N/A
  • Industry
  • EPR Real Estate Investment Trusts
  • BLCO Ophthalmic Goods
  • Sector
  • EPR Real Estate
  • BLCO Health Care
  • Exchange
  • EPR Nasdaq
  • BLCO Nasdaq
  • Market Cap
  • EPR 4.1B
  • BLCO 4.0B
  • IPO Year
  • EPR 1997
  • BLCO 2022
  • Fundamental
  • Price
  • EPR $55.75
  • BLCO $11.51
  • Analyst Decision
  • EPR Hold
  • BLCO Hold
  • Analyst Count
  • EPR 11
  • BLCO 12
  • Target Price
  • EPR $52.30
  • BLCO $15.59
  • AVG Volume (30 Days)
  • EPR 651.0K
  • BLCO 865.4K
  • Earning Date
  • EPR 05-07-2025
  • BLCO 04-30-2025
  • Dividend Yield
  • EPR 6.20%
  • BLCO N/A
  • EPS Growth
  • EPR N/A
  • BLCO N/A
  • EPS
  • EPR 1.63
  • BLCO N/A
  • Revenue
  • EPR $697,032,000.00
  • BLCO $4,829,000,000.00
  • Revenue This Year
  • EPR N/A
  • BLCO $6.97
  • Revenue Next Year
  • EPR $2.23
  • BLCO $5.44
  • P/E Ratio
  • EPR $34.12
  • BLCO N/A
  • Revenue Growth
  • EPR 0.70
  • BLCO 11.94
  • 52 Week Low
  • EPR $39.87
  • BLCO $10.45
  • 52 Week High
  • EPR $55.92
  • BLCO $21.69
  • Technical
  • Relative Strength Index (RSI)
  • EPR 66.40
  • BLCO 43.78
  • Support Level
  • EPR $51.64
  • BLCO $11.30
  • Resistance Level
  • EPR $55.92
  • BLCO $12.05
  • Average True Range (ATR)
  • EPR 0.99
  • BLCO 0.38
  • MACD
  • EPR 0.19
  • BLCO 0.07
  • Stochastic Oscillator
  • EPR 83.08
  • BLCO 39.62

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: